Alignment Healthcare, Inc. (ALHC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 2B 4B 6B Q3 '21: 1.1B Q4 '21: 1.2B Q1 '22: 1.2B Q2 '22: 1.3B Q3 '22: 1.4B Q4 '22: 1.4B Q1 '23: 1.5B Q2 '23: 1.6B Q3 '23: 1.7B Q4 '23: 1.8B Q1 '24: 2B Q2 '24: 2.2B Q3 '24: 2.5B Q4 '24: 2.7B Q1 '25: 3B Q2 '25: 3.3B Q3 '25: 3.6B Q4 '25: 3.9B Q1 '26: 4.3B Q2 '26: 4.6B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

-210M -140M -70M 0 70M 140M 210M Q3 '21: -162.4M Q4 '21: -178.1M Q1 '22: -161.9M Q2 '22: -128M Q3 '22: -120M Q4 '22: -128.6M Q1 '23: -124.7M Q2 '23: -141.7M Q3 '23: -138M Q4 '23: -127.8M Q1 '24: -136.4M Q2 '24: -131.2M Q3 '24: -120.9M Q4 '24: -101.6M Q1 '25: -65.8M Q2 '25: -24.7M Q3 '25: 2.5M Q4 '25: 14.8M Q1 '26: 35.6M Q2 '26: 55M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-210M -140M -70M 0 70M 140M 210M Q3 '21: -179.5M Q4 '21: -195.3M Q1 '22: -179.2M Q2 '22: -146M Q3 '22: -140.5M Q4 '22: -149.5M Q1 '23: -146M Q2 '23: -162.9M Q3 '23: -157.7M Q4 '23: -148M Q1 '24: -157.3M Q2 '24: -152.8M Q3 '24: -144.2M Q4 '24: -128M Q1 '25: -90.6M Q2 '25: -51M Q3 '25: -20.8M Q4 '25: -724K Q1 '26: 19.8M Q2 '26: 40.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-140M -70M 0 70M 140M 210M Q4 '20: 7.6M Q1 '21: -8.7M Q2 '21: -45.7M Q3 '21: -58.8M Q4 '21: -78.8M Q1 '22: -52.3M Q2 '22: -18.5M Q3 '22: 73.7M Q4 '24: 34.8M Q1 '25: 57.6M Q2 '25: 63.2M Q3 '25: 181.6M Q1 '21 Q3 '21 Q1 '22 Q3 '22 Q1 '25 Q3 '25

Free Cash Flow TTM

-60M 0 60M 120M 180M Q4 '24: -6.6M Q1 '25: 19.1M Q2 '25: 28.4M Q3 '25: 150.6M Q4 '24 Q1 '25 Q2 '25 Q3 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 80M 160M 240M Q1 '20: 0 Q1 '21: 12.6M Q1 '22: 16.2M Q3 '22: 187.3M Q1 '23: 183.1M Q2 '23: 186M Q3 '23: 187.3M Q1 '24: 189M Q2 '24: 190.9M Q3 '24: 191.4M Q1 '25: 193.6M Q2 '25: 209.5M Q3 '25: 208.9M Q1 '26: 213.1M Q2 '26: 215M Q1 '20 Q1 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.05 -0.70 -0.35 0.00 0.35 0.70 1.05 Q4 '20: -0.16 Q1 '23: -0.80 Q2 '23: -0.89 Q3 '23: -0.86 Q4 '23: -0.79 Q1 '24: -0.84 Q2 '24: -0.82 Q3 '24: -0.77 Q4 '24: -0.68 Q1 '25: -0.48 Q2 '25: -0.28 Q3 '25: -0.12 Q4 '25: -0.00 Q1 '26: 0.10 Q2 '26: 0.20 Q4 '20 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.